# 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

> **NCT00159796** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 489 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Olanzapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00159796
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-14
- **Primary completion:** 2006-03-28
- **Final completion:** 2006-04-28
- **Target enrollment:** 489 (ACTUAL)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00159796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00159796, "3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00159796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*